Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Hypha Labs (FUNI) Return on Sales (2016 - 2025)

Hypha Labs' Return on Sales history spans 15 years, with the latest figure at 15.9% for Q3 2025.

  • For Q3 2025, Return on Sales rose 1880.0% year-over-year to 15.9%; the TTM value through Sep 2025 reached 29.89%, up 3279.0%, while the annual FY2025 figure was 29.22%, 3212.0% up from the prior year.
  • Return on Sales reached 15.9% in Q3 2025 per FUNI's latest filing, down from 21.62% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 66.97% in Q4 2024 to a low of 4.95% in Q3 2023.
  • Average Return on Sales over 5 years is 5.65%, with a median of 0.23% recorded in 2021.
  • Peak YoY movement for Return on Sales: crashed -506bps in 2023, then soared 7044bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 0.4% in 2021, then surged by 107bps to 0.03% in 2022, then plummeted by -13266bps to 3.47% in 2023, then soared by 2030bps to 66.97% in 2024, then tumbled by -76bps to 15.9% in 2025.
  • Per Business Quant, the three most recent readings for FUNI's Return on Sales are 15.9% (Q3 2025), 21.62% (Q2 2025), and 28.32% (Q1 2025).